Enhanced premium tax credits are set to expire at the end of 2025.

Question

Accepted Answer

Pharmacy spending rose 7.2% in 2024 versus 5.1% for hospital care, according to Mercer claims data. GLP-1 weight-loss drugs and gene therapies (some costing $1-4 million per treatment) accounted for most of the pharmacy spike. Employers can't negotiate drug prices directly—pharmacy benefit managers (PBMs) like Express Scripts control formularies and pocket rebates that average 30-50% of list prices but rarely pass full savings to employers.

Enhanced premium tax credits are set to expire at the end of 2025.

Explanation

Sources

Related Questions

PRINCIPLE

EXPLORE

RESOURCES